We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ML:EURONEXT PARISCie Generale des Etablissements Michelin SA Analysis

Data as of 2026-05-25 - not real-time

$133.39

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mueller Industries is generating strong top‑line momentum with a 19% revenue growth rate and an impressive 28% return on equity, while maintaining a solid cash position of $1.4 bn against minimal debt. Valuation metrics indicate the stock trades at a 17.5× PE, well below the industry average of 29.7×, and the discounted cash‑flow model suggests a fair value of $141.8, implying roughly 12% upside from the current $133.4 price. The dividend yield of 1.05% is modest but the payout ratio of just 14% points to a sustainable income stream. Technical indicators show the price sitting above the 50‑day and 200‑day SMAs, supporting a bullish trend, yet it remains below the 20‑day SMA and the MACD histogram is negative, signaling short‑term caution. Volatility is elevated at 41% over the past 30 days and a beta of 1.14 suggests the stock moves slightly more than the market. The current support at $130.2 and resistance at $141.5 frame the near‑term trading range, while the “Extreme Greed” market sentiment adds a layer of optimism. Overall, the combination of robust fundamentals, undervalued pricing relative to peers, and a sustainable dividend makes the stock attractive for medium‑ to long‑term investors, though the near‑term technical mixed signals advise a measured approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at $130.2
  • Bullish long‑term SMA alignment but bearish MACD histogram
  • High 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE vs industry and DCF upside of ~12%
  • Strong revenue growth and 28% ROE
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable cash generation and low debt levels
  • Consistent profitability and high operating margins
  • Favorable valuation relative to peers and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth19.30%
Profit Margin19.37%
P/E Ratio17.5
ROE28.30%
ROA17.04%
Debt/Equity0.68
P/B Ratio4.4
Op. Cash Flow$721.6M
Free Cash Flow$498.6M
Industry P/E29.7

Technical Analysis

TrendBullish
RSI51.5
Support$130.22
Resistance$141.51
MA 20$136.10
MA 50$124.61
MA 200$113.26
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$141.84
Target Price$149.50
Upside/Downside12.08%
GradeUndervalued
TypeGrowth
Dividend Yield1.05%

Risk Assessment

Beta1.14
Volatility41.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.